141 related articles for article (PubMed ID: 28707321)
1. Expansion of BCR/ABL1
Edlinger L; Berger-Becvar A; Menzl I; Hoermann G; Greiner G; Grundschober E; Bago-Horvath Z; Al-Zoughbi W; Hoefler G; Brostjan C; Gille L; Moriggl R; Spittler A; Sexl V; Hoelbl-Kovacic A
Br J Haematol; 2017 Oct; 179(2):229-241. PubMed ID: 28707321
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells.
Gopal SK; Greening DW; Hanssen EG; Zhu HJ; Simpson RJ; Mathias RA
Oncotarget; 2016 Apr; 7(15):19709-22. PubMed ID: 26919098
[TBL] [Abstract][Full Text] [Related]
3. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
Siu MK; Wong ES; Chan HY; Kong DS; Woo NW; Tam KF; Ngan HY; Chan QK; Chan DC; Chan KY; Cheung AN
Int J Cancer; 2010 Jul; 127(1):21-31. PubMed ID: 19876919
[TBL] [Abstract][Full Text] [Related]
4. p21-Activated Kinase 2 Regulates Endothelial Development and Function through the Bmk1/Erk5 Pathway.
Radu M; Lyle K; Hoeflich KP; Villamar-Cruz O; Koeppen H; Chernoff J
Mol Cell Biol; 2015 Dec; 35(23):3990-4005. PubMed ID: 26391956
[TBL] [Abstract][Full Text] [Related]
5. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.
Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN
PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748
[TBL] [Abstract][Full Text] [Related]
6. PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.
Chung EY; Mai Y; Shah UA; Wei Y; Ishida E; Kataoka K; Ren X; Pradhan K; Bartholdy B; Wei X; Zou Y; Zhang J; Ogawa S; Steidl U; Zang X; Verma A; Janakiram M; Ye BH
Clin Cancer Res; 2019 Jun; 25(12):3589-3601. PubMed ID: 30862694
[TBL] [Abstract][Full Text] [Related]
7. PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions.
Grebeňová D; Holoubek A; Röselová P; Obr A; Brodská B; Kuželová K
Sci Rep; 2019 Nov; 9(1):17171. PubMed ID: 31748572
[TBL] [Abstract][Full Text] [Related]
8. PAK1 and PAK2 have different roles in HGF-induced morphological responses.
Bright MD; Garner AP; Ridley AJ
Cell Signal; 2009 Dec; 21(12):1738-47. PubMed ID: 19628037
[TBL] [Abstract][Full Text] [Related]
9. Insulin-stimulated glucose uptake partly relies on p21-activated kinase (PAK)2, but not PAK1, in mouse skeletal muscle.
Møller LLV; Jaurji M; Kjøbsted R; Joseph GA; Madsen AB; Knudsen JR; Lundsgaard AM; Andersen NR; Schjerling P; Jensen TE; Krauss RS; Richter EA; Sylow L
J Physiol; 2020 Dec; 598(23):5351-5377. PubMed ID: 32844438
[TBL] [Abstract][Full Text] [Related]
10. PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).
Hawley E; Gehlhausen J; Karchugina S; Chow HY; Araiza-Olivera D; Radu M; Smith A; Burks C; Jiang L; Li X; Bessler W; Masters A; Edwards D; Burgin C; Jones D; Yates C; Clapp DW; Chernoff J; Park SJ
Hum Mol Genet; 2021 Aug; 30(17):1607-1617. PubMed ID: 34075397
[TBL] [Abstract][Full Text] [Related]
11. The p21-activated kinase 2 (PAK2), but not PAK1, regulates contraction-stimulated skeletal muscle glucose transport.
Møller LLV; Nielsen IL; Knudsen JR; Andersen NR; Jensen TE; Sylow L; Richter EA
Physiol Rep; 2020 Jun; 8(12):e14460. PubMed ID: 32597567
[TBL] [Abstract][Full Text] [Related]
12. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism.
Raimondo S; Saieva L; Corrado C; Fontana S; Flugy A; Rizzo A; De Leo G; Alessandro R
Cell Commun Signal; 2015 Feb; 13():8. PubMed ID: 25644060
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal hormones/neurotransmitters and growth factors can activate P21 activated kinase 2 in pancreatic acinar cells by novel mechanisms.
Nuche-Berenguer B; Jensen RT
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2371-82. PubMed ID: 25979836
[TBL] [Abstract][Full Text] [Related]
14. Pak1 and Pak2 mediate tumor cell invasion through distinct signaling mechanisms.
Coniglio SJ; Zavarella S; Symons MH
Mol Cell Biol; 2008 Jun; 28(12):4162-72. PubMed ID: 18411304
[TBL] [Abstract][Full Text] [Related]
15. PAK1 and PAK2 in cell metabolism regulation.
Kořánová T; Dvořáček L; Grebeňová D; Röselová P; Obr A; Kuželová K
J Cell Biochem; 2022 Feb; 123(2):375-389. PubMed ID: 34750857
[TBL] [Abstract][Full Text] [Related]
16. Group I Paks Promote Skeletal Myoblast Differentiation In Vivo and In Vitro.
Joseph GA; Lu M; Radu M; Lee JK; Burden SJ; Chernoff J; Krauss RS
Mol Cell Biol; 2017 Feb; 37(4):. PubMed ID: 27920252
[TBL] [Abstract][Full Text] [Related]
17. Late-onset megaconial myopathy in mice lacking group I Paks.
Joseph GA; Hung M; Goel AJ; Hong M; Rieder MK; Beckmann ND; Serasinghe MN; Chipuk JE; Devarakonda PM; Goldhamer DJ; Aldana-Hernandez P; Curtis J; Jacobs RL; Krauss RS
Skelet Muscle; 2019 Feb; 9(1):5. PubMed ID: 30791960
[TBL] [Abstract][Full Text] [Related]
18. Potential compensation among group I PAK members in hindlimb ischemia and wound healing.
Elsherif L; Ozler M; Zayed MA; Shen JH; Chernoff J; Faber JE; Parise LV
PLoS One; 2014; 9(11):e112239. PubMed ID: 25379771
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
Tabusa H; Brooks T; Massey AJ
Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
[TBL] [Abstract][Full Text] [Related]
20. Group I p21-activated kinases in leukemia cell adhesion to fibronectin.
Kuželová K; Obr A; Röselová P; Grebeňová D; Otevřelová P; Brodská B; Holoubek A
Cell Adh Migr; 2021 Dec; 15(1):18-36. PubMed ID: 33464167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
